R. Jayachandra Babu
Title
Cited by
Cited by
Year
Nanomedicine scale-up technologies: feasibilities and challenges
R Paliwal, RJ Babu, S Palakurthi
Aaps Pharmscitech 15 (6), 1527-1534, 2014
1752014
Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement
SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu
Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012
1212012
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes
S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ...
Aaps Pharmscitech 10 (1), 81-87, 2009
1042009
In vitro and in vivo evaluation of topical formulations of spantide II
L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh
Aaps Pharmscitech 6 (4), E565-E572, 2005
952005
Formulation of controlled release gellan gum macro beads of amoxicillin
RJ Babu, S Sathigari, MT Kumar, JK Pandit
Current drug delivery 7 (1), 36-43, 2010
902010
Role of cyclodextrins in nanoparticle-based drug delivery systems
H Shelley, RJ Babu
Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018
892018
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin
RJ Babu, JK Pandit
International journal of pharmaceutics 271 (1-2), 155-165, 2004
832004
Formulation and in vitro evaluation of transdermal patches of melatonin
N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh
Drug development and industrial pharmacy 30 (2), 205-212, 2004
832004
Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems
RJ Babu, JK Pandit
International journal of pharmaceutics 288 (2), 325-334, 2005
802005
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size …
P Dayal, V Pillay, RJ Babu, M Singh
Aaps Pharmscitech 6 (4), E573-E585, 2005
732005
Alternatives to biological skin in permeation studies: Current trends and possibilities
R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari
Pharmaceutics 12 (2), 152, 2020
712020
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro
L Kikwai, N Kanikkannan, RJ Babu, M Singh
Journal of controlled release 83 (2), 307-311, 2002
632002
Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin
RJ Babu, JK Pandit
Drug delivery 12 (3), 165-169, 2005
552005
Lipid materials for topical and transdermal delivery of nanoemulsions
KR Pawar, RJ Babu
Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014
492014
The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide
RJ Babu, N Kanikkannan, L Kikwai, C Ortega, S Andega, K Ball, S Yim, ...
Journal of controlled release 86 (1), 49-57, 2003
492003
Biomaterial-derived calcium carbonate nanoparticles for enteric drug delivery
D Render, T Samuel, H King, M Vig, S Jeelani, RJ Babu, V Rangari
Journal of nanomaterials 2016, 2016
442016
Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement
GP Sanganwar, S Sathigari, RJ Babu, RB Gupta
European Journal of Pharmaceutical Sciences 39 (1-3), 164-174, 2010
412010
Effect of cyclodextrins on the complexation and nasal permeation of melatonin
RJ Babu, P Dayal, M Singh
Drug delivery 15 (6), 381-388, 2008
412008
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: An insight from the published in vitro, preclinical and clinical studies
RP Dash, RJ Babu, NR Srinivas
European journal of drug metabolism and pharmacokinetics 42 (6), 915-933, 2017
402017
Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics
RP Dash, RJ Babu, NR Srinivas
Clinical pharmacokinetics 57 (11), 1385-1398, 2018
372018
The system can't perform the operation now. Try again later.
Articles 1–20